TickerFacts.

Immucell Corp (ICCC): Long-Term Debt

Annual figures by period end, from SEC filings.

$9.10M
As of 2025-12-31
$8.30M
As of 2026-06-30
-3.8%
3-year compound annual growth
-0.9%
5-year compound annual growth
$10.23M2011-12-31: $1.34M2012-12-31: $1.17M2013-12-31: $929.2K2017-12-31: $8.96M2018-12-31: $9.27M2019-12-31: $8.42M2020-12-31: $9.50M2021-12-31: $812.2K2022-12-31: $10.23M2025-12-31: $9.10M$9.10M
2011-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$9.10Mn/a2026-03-30, Balance as of period end
No annual figure between 2022-12-31 and 2025-12-31.
2022-12-31$10.23Mn/m2023-03-29, Balance as of period end
2021-12-31$812.2K-91.4%2022-03-30, Balance as of period end
2020-12-31$9.50M+12.8%2021-03-30, Balance as of period end
2019-12-31$8.42M-9.1%2020-03-27, Balance as of period end
2018-12-31$9.27M+3.5%2019-03-22, Balance as of period end
2017-12-31$8.96Mn/a2018-03-29, Balance as of period end
No annual figure between 2013-12-31 and 2017-12-31.
2013-12-31$929.2K-20.6%2014-03-26, Balance as of period end
2012-12-31$1.17M-12.4%2014-03-26, Balance as of period end
2011-12-31$1.34Mn/a2013-03-28, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Immucell Corp (ICCC)2025-12-31$9.10Mn/a
Alpha Teknova, Inc. (TKNO)2025-12-31$13.12M+39.0%
Aspira Women's Health Inc. (AWHL)2025-12-31$1.28M-15.3%
Volitionrx Ltd (VNRX)2025-12-31$6.71M+39.4%
Myriad Genetics Inc (MYGN)2025-12-31$119.90Mn/a
QuidelOrtho Corp (QDEL)2025-12-28$2.70B+8.4%
Idexx Laboratories Inc (IDXX)2025-12-31$450.00M-27.2%

Compare ICCC, TKNO, AWHL, VNRX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗